Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database

Shah Manish A.; Renfro Lindsay A.; Allegra Carmen J.; Andre Thierry; de Gramont Aimery; Schmoll Hans-Joachim; Haller Daniel G.; Alberts Steven R.; Yothers Greg; Sargent Daniel J.

首页> 外文期刊>Journal of Clinical Oncology >Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database

【24h】

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database

机译：患者因素对结肠癌患者复发风险和奥沙利铂获益时间依赖性的影响：佐剂结肠癌终点数据库（ACCENT）中现代时代佐剂研究的分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2016年第8期|共14页
作者
Shah Manish A.; Renfro Lindsay A.; Allegra Carmen J.; Andre Thierry; de Gramont Aimery; Schmoll Hans-Joachim; Haller Daniel G.; Alberts Steven R.; Yothers Greg; Sargent Daniel J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database [J] . Shah Manish A., Renfro Lindsay A., Allegra Carmen J., Journal of Clinical Oncology . 2016,第8期

机译：患者因素对结肠癌患者复发风险和奥沙利铂获益时间依赖性的影响：佐剂结肠癌终点数据库（ACCENT）中现代时代佐剂研究的分析
2. Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study [J] . Liang Yi-Hsin, Shao Yu-Yun, Chen Ho-Min, Anticancer Research: International Journal of Cancer Research and Treatment . 2017,第12期

机译：Irinotecan和Oxaliplatin可以为可重型同步结肠癌和肝限局限性转移患者提供平等的益处，辅助化疗：全国数据库研究
3. Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study [J] . ?ok Jolanta, Bieńkowski Micha?, Radecka Barbara, BMC Cancer . 2021,第1期

机译：oxaliplatin相对剂量强度在早期复发期阶段结肠癌患者辅助治疗中的影响：回顾性队列研究
4. Adjuvant Chemotherapy Should Not Routinely Be Recommended to Patients with Stage II Colon Cancers that Manifest Microsatellite Instability [C] . Sigurdis Haraldsdottir, Richard M. Goldberg Gastrointestinal Cancers Symposium . 2014

机译：不应常规向患有阶段结肠癌的患者常规的辅助化学疗法，表明微卫星不稳定性
5. Adherence to adjuvant chemotherapy and post-treatment surveillance in a large community-based cohort of patients with colon cancer. [D] . Hu, Chung-Yuan. 2010

机译：在结肠癌患者的大型社区队列中坚持辅助化疗和治疗后监测。
6. Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database [O] . Manish A. Shah, Lindsay A. Renfro, Carmen J. Allegra, -1

机译：患者因素对结肠癌患者复发风险和奥沙利铂获益时间依赖性的影响：佐剂结肠癌终点数据库（ACCENT）中现代时代佐剂研究的分析
7. Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study [O] . 2017

机译：Irinotecan和Oxaliplatin可以为辅助化疗提供平等的益处，用于可重型同步结肠癌和肝限局限性转移患者：全国范围内的数据库研究

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database

摘要

著录项

相似文献

相关主题

期刊订阅